WallStreetZenWallStreetZen

NASDAQ: CLOV
CLOVER HEALTH INVESTMENTS CORP Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CLOV

Based on 5 analysts offering 12 month price targets for CLOVER HEALTH INVESTMENTS CORP.
Min Forecast
$3.00+10.29%
Avg Forecast
$6.20+127.94%
Max Forecast
$10.00+267.65%

Should I buy or sell CLOV stock?

Based on 5 analysts offering ratings for CLOVER HEALTH INVESTMENTS CORP.
Hold
Strong Buy
1 analysts 20%
Buy
0 analysts 0%
Hold
3 analysts 60%
Sell
1 analysts 20%
Strong Sell
0 analysts 0%

CLOV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
SVB Leerink
Top 37%
64
HoldMaintains$3.00+10.29%2022-05-10
Canaccord Genuity
Bottom 4%
4
Strong BuyInitiates Coverage On$6.00+120.59%2022-02-02
Cowen & Co.
Bottom 6%
6
HoldUpgrades$3.00+10.29%2022-02-02
Anonymous
Credit Suisse
SellDowngrades$3.50+28.68%2022-01-07
Credit Suisse
Bottom 41%
41
HoldMaintains$9.00+230.88%2021-11-15
Bank of America
Bottom 7%
7
SellDowngrades$10.00+267.65%2021-06-10

1 of 1

Forecast return on equity

Is CLOV forecast to generate an efficient return?
Company
-10.63%
Industry
36.25%
Market
32.81%
CLOV's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CLOV forecast to generate an efficient return on assets?
Company
-1.94%
Industry
11.99%
CLOV is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CLOV earnings per share forecast

What is CLOV's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.04
Avg 2 year Forecast
-$0.72
Avg 3 year Forecast
-$0.38

CLOV revenue forecast

What is CLOV's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$3.4B+57.76%
Avg 2 year Forecast
$4.4B+104.7%
Avg 3 year Forecast
$5.7B+167.54%
CLOV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CLOV revenue growth forecast

How is CLOV forecast to perform vs Healthcare Plans companies and vs the US market?
Company
38.03%
Industry
7.46%
Market
9.2%
CLOV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLOV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLOV vs Healthcare Plan Stocks

TickerPricePrice TargetUp/downsideConsensus
CLOV$2.72$6.20+127.94%Hold
BHG$1.95$10.54+440.62%Buy
OSCR$5.67$13.50+138.10%Buy
ALHC$9.42$21.38+126.91%Strong Buy
MRAI$1.36N/AN/A
View Top Healthcare Plan Stocks

CLOVER HEALTH INVESTMENTS Stock Forecast FAQ

Is CLOVER HEALTH INVESTMENTS Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: CLOV) stock is to Hold CLOV stock.

Out of 5 analysts, 1 (20%) are recommending CLOV as a Strong Buy, 0 (0%) are recommending CLOV as a Buy, 3 (60%) are recommending CLOV as a Hold, 1 (20%) are recommending CLOV as a Sell, and 0 (0%) are recommending CLOV as a Strong Sell.

What is CLOV's earnings growth forecast for 2022-2024?

(NASDAQ: CLOV) CLOVER HEALTH INVESTMENTS's forecast annual earnings growth rate of N/A is not forecast to beat the US Healthcare Plans industry's average forecast earnings growth rate of 14.7%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.78%.

CLOVER HEALTH INVESTMENTS's earnings in 2022 is -$614,648,000.On average, 1 Wall Street analyst forecast CLOV's earnings for 2022 to be -$492,297,266, with the lowest CLOV earnings forecast at -$492,297,266, and the highest CLOV earnings forecast at -$492,297,266. On average, 2 Wall Street analysts forecast CLOV's earnings for 2023 to be -$340,821,184, with the lowest CLOV earnings forecast at -$388,157,460, and the highest CLOV earnings forecast at -$288,751,281.

In 2024, CLOV is forecast to generate -$179,877,847 in earnings, with the lowest earnings forecast at -$179,877,847 and the highest earnings forecast at -$179,877,847.

What is CLOV's revenue growth forecast for 2022-2024?

(NASDAQ: CLOV) CLOVER HEALTH INVESTMENTS's forecast annual revenue growth rate of 38.03% is forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 7.46%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.2%.

CLOVER HEALTH INVESTMENTS's revenue in 2022 is $2,146,050,000.On average, 2 Wall Street analysts forecast CLOV's revenue for 2022 to be $1,602,645,348,479, with the lowest CLOV revenue forecast at $1,575,019,898,039, and the highest CLOV revenue forecast at $1,630,270,798,919. On average, 2 Wall Street analysts forecast CLOV's revenue for 2023 to be $2,079,439,984,460, with the lowest CLOV revenue forecast at $2,071,444,887,511, and the highest CLOV revenue forecast at $2,087,435,081,409.

In 2024, CLOV is forecast to generate $2,717,812,263,574 in revenue, with the lowest revenue forecast at $2,717,812,263,574 and the highest revenue forecast at $2,717,812,263,574.

What is CLOV's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: CLOV) forecast ROA is -1.94%, which is lower than the forecast US Healthcare Plans industry average of 11.99%.

What is CLOV's Price Target?

According to 5 Wall Street analysts that have issued a 1 year CLOV price target, the average CLOV price target is $6.20, with the highest CLOV stock price forecast at $10.00 and the lowest CLOV stock price forecast at $3.00.

On average, Wall Street analysts predict that CLOVER HEALTH INVESTMENTS's share price could reach $6.20 by May 10, 2023. The average CLOVER HEALTH INVESTMENTS stock price prediction forecasts a potential upside of 127.94% from the current CLOV share price of $2.72.

What is CLOV's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: CLOV) CLOVER HEALTH INVESTMENTS's current Earnings Per Share (EPS) is -$1.46. On average, analysts forecast that CLOV's EPS will be -$1.04 for 2022, with the lowest EPS forecast at -$1.04, and the highest EPS forecast at -$1.04. On average, analysts forecast that CLOV's EPS will be -$0.72 for 2023, with the lowest EPS forecast at -$0.82, and the highest EPS forecast at -$0.61. In 2024, CLOV's EPS is forecast to hit -$0.38 (min: -$0.38, max: -$0.38).

What is CLOV's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: CLOV) forecast ROE is -10.63%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.